If you have a history of severe allergic reaction after a previous dose of any hepatitis B vaccine, or to any ingredient of HEPLISAV‑B, including yeast, do not take HEPLISAV‑B.
This website is intended for US audiences only
*Compared to those who received 3 doses of Engerix‑B
Be sure to complete all doses of HEPLISAV‑B to be protected
of adults in pivotal clinical trials who received HEPLISAV‑B were protected after completing 2 doses in 1 month†
†Compared to 79.5% who received 3 doses of Engerix‑B. 12,344 participants aged 18–70.
HEPLISAV‑B was studied in clinical trials of more than 10,000 patients.
The most common side effects include pain at the injection site, tiredness, and headache.
Most healthcare insurance plans will cover a CDC-recommended vaccine like HEPLISAV‑B. Ask your doctor or pharmacist about vaccination coverage and reimbursement to learn more.
Find a PharmacyHepatitis B has no cure, but it can be prevented‡
Talk to your healthcare provider or pharmacist about HEPLISAV‑B, the first and only adult 2‑dose vaccine for hepatitis B
‡For most people, hepatitis B clears on its own. For those who don’t clear the virus, the resulting health complications can be lifelong or even deadly. There is no way of definitively knowing who will clear the virus and who will not.
CDC=Centers for Disease Control and Prevention
This site uses cookies to improve your experience. By continuing to use this website you are agreeing to our Cookie Policy.
This site uses cookies to improve your experience. By continuing to use this website you are agreeing to our Cookie Policy.
HEPLISAV‑B is a shot given to adults 18 years of age and older to help prevent infection caused by the hepatitis B virus.
HEPLISAV‑B is usually given in the arm muscle. HEPLISAV‑B is given in 2 doses, 1 month apart, by a healthcare provider.
IMPORTANT SAFETY INFORMATION
If you have a history of severe allergic reaction after a previous dose of any hepatitis B vaccine, or to any ingredient of HEPLISAV‑B, including yeast, do not take HEPLISAV‑B.
HEPLISAV‑B must be given by a medical professional, who will monitor you afterwards, to check for allergic reaction.
If you are immunocompromised, or receiving immunosuppressant therapy, you may have less of an immune response to HEPLISAV‑B.
Some people have hepatitis B infection without being aware of it or showing any symptoms. If you already have hepatitis B present in your body, HEPLISAV‑B may not prevent hepatitis B infection.
The most common side effects include pain at the injection site, tiredness, and headache.
HEPLISAV‑B was not studied in pregnant or nursing women. Tell your provider if you are pregnant or plan to become pregnant or are breast feeding.
Vaccination with HEPLISAV‑B may not protect all individuals.
Talk to your healthcare provider to determine if HEPLISAV‑B is right for you.
ADDITIONAL IMPORTANT INFORMATION
HEPLISAV‑B does not treat liver diseases such as cirrhosis or liver cancer.
Not all liver cancer is caused by the hepatitis B virus.
